Compare SDA & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDA | HYFT |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | China | United States |
| Employees | 544 | 102 |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.4M | 71.9M |
| IPO Year | N/A | N/A |
| Metric | SDA | HYFT |
|---|---|---|
| Price | $0.77 | $1.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.75 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 1.7M | 569.5K |
| Earning Date | 04-28-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.01 | N/A |
| Revenue Next Year | $15.55 | $29.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.47 | $0.99 |
| 52 Week High | $2.93 | $3.00 |
| Indicator | SDA | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 50.41 |
| Support Level | $0.47 | $1.56 |
| Resistance Level | $2.12 | $1.96 |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 27.35 | 7.02 |
SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.